2ZF3 | pdb_00002zf3

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
F	Abhydrolase_1	e2zf3F1	A: alpha bundles	X: HTH	H: Nudix	T: Nudix	F: Abhydrolase_1	ECOD (develop294)
E	Abhydrolase_1	e2zf3E1	A: alpha bundles	X: HTH	H: Nudix	T: Nudix	F: Abhydrolase_1	ECOD (develop294)
D	Abhydrolase_1	e2zf3D1	A: alpha bundles	X: HTH	H: Nudix	T: Nudix	F: Abhydrolase_1	ECOD (develop294)
C	Abhydrolase_1	e2zf3C1	A: alpha bundles	X: HTH	H: Nudix	T: Nudix	F: Abhydrolase_1	ECOD (develop294)
B	Abhydrolase_1	e2zf3B1	A: alpha bundles	X: HTH	H: Nudix	T: Nudix	F: Abhydrolase_1	ECOD (develop294)
A	Abhydrolase_1	e2zf3A1	A: alpha bundles	X: HTH	H: Nudix	T: Nudix	F: Abhydrolase_1	ECOD (develop294)

Chain	Domain	Class	Architecture	Topology	Provenance Source (Version)
F	2.50.20.30	Mainly Beta	Clam	outer membrane lipoprotein receptor (LolB), chain A	CATH (4.3.0)
E	2.50.20.30	Mainly Beta	Clam	outer membrane lipoprotein receptor (LolB), chain A	CATH (4.3.0)
D	2.50.20.30	Mainly Beta	Clam	outer membrane lipoprotein receptor (LolB), chain A	CATH (4.3.0)
C	2.50.20.30	Mainly Beta	Clam	outer membrane lipoprotein receptor (LolB), chain A	CATH (4.3.0)
B	2.50.20.30	Mainly Beta	Clam	outer membrane lipoprotein receptor (LolB), chain A	CATH (4.3.0)
A	2.50.20.30	Mainly Beta	Clam	outer membrane lipoprotein receptor (LolB), chain A	CATH (4.3.0)

Chains	Accession	Name	Description	Comments	Source
A, B, C, D, E A, B, C, D, E, F	PF18234	Violacein biosynthetic enzyme VioE (VioE)	Violacein biosynthetic enzyme VioE	This domain is VioE present in Chromobacterium violaceum. VioE plays a key role in the biosynthesis of violacein. Violacein has potential medical applications as an antibacterial, anti-tryptanocidal, anti-ulcerogenic and as an anti-cancer drug. VioE ...	This domain is VioE present in Chromobacterium violaceum. VioE plays a key role in the biosynthesis of violacein. Violacein has potential medical applications as an antibacterial, anti-tryptanocidal, anti-ulcerogenic and as an anti-cancer drug. VioE forms a homodimer with a chiefly hydrophobic interface between the two VioE monomers.The fact that VioE adopts a fold normally associated with lipoprotein carrier proteins may be due to VioE for binding the hydrophobic polyethylene glycol [1].	Domain

Chains	Accession	Name	Type
A, B, C, D, E A, B, C, D, E, F	IPR019902	Violacein biosynthesis enzyme, VioE	Family
A, B, C, D, E A, B, C, D, E, F	IPR038642	VioE superfamily	Homologous Superfamily
A, B, C, D, E A, B, C, D, E, F	IPR040857	VioE domain	Domain